Guardant Health Revenue and Competitors
Estimated Revenue & Valuation
- Guardant Health's estimated annual revenue is currently $343.9M per year.
- Guardant Health received $360.0M in venture funding in May 2017.
- Guardant Health's estimated revenue per employee is $108,268
- Guardant Health's total funding is $550M.
- Guardant Health's current valuation is $7.9B. (January 2022)
Employee Data
- Guardant Health has 3176 Employees.
- Guardant Health grew their employee count by 7% last year.
Guardant Health's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman And Co-CEO | Reveal Email/Phone |
2 | Co-CEO | Reveal Email/Phone |
3 | Chief People Officer | Reveal Email/Phone |
4 | Senior Executive Assistant to Chief Commercial Officer | Reveal Email/Phone |
5 | Chief Legal Officer | Reveal Email/Phone |
6 | Chief Commercial Officer | Reveal Email/Phone |
7 | Chief Information Officer | Reveal Email/Phone |
8 | Chief Medical Officer | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Chief Technology Officer | Reveal Email/Phone |
Guardant Health Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4280M | 11139 | -4% | $28M | $63.3B |
#2 | $564.8M | 3872 | 6% | $404.1M | $6.4B |
#3 | $454.5M | 6622 | 6% | $1B | N/A |
#4 | $423.6M | 1708 | 5% | $2B | $2.5B |
#5 | $434.8M | 1865 | -14% | $2B | $2.7B |
What Is Guardant Health?
We believe conquering cancer is a big data problem. That's why we built the world's leading comprehensive liquid biopsy. This non-invasive tool for accessing and sequencing tumor DNA is used by thousands of oncologists to help tens of thousands of advanced cancer patients. We believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. We're working on some exciting ones, including in early detection, where the impact on patients can be profound. We've raised more than $500 million from investors including Sequoia Capital, Khosla Ventures, OrbiMed, and SoftBank.
keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals
$550M
Total Funding
3176
Number of Employees
$343.9M
Revenue (est)
7%
Employee Growth %
$7.9B
Valuation
N/A
Accelerator
Guardant Health News
SAN DIEGO Bay Area biotech Guardant Health is closer than ever to its ultimate goal developing and deploying a simple, blood-based test...
That average ranking earns Guardant Health Inc an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by...
SAN DIEGO Bay Area biotech Guardant Health is closer than ever to its ultimate goal developing and deploying a simple, blood-based test...
That average ranking earns Guardant Health Inc an Analyst Rating of 68, which is better than 68% of stocks based on data compiled by...
Other Companies in Redwood City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $648.8M | 3241 | 0% | $477.4M |
#2 | $839.9M | 3472 | 4% | $1.1B |
#3 | $1259.7M | 3599 | 2% | N/A |
#4 | $300M | 4069 | 7% | N/A |
#5 | $1526M | 5396 | 96% | N/A |
Guardant Health Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-02-12 | $10.0M | Undisclosed | Sequoia Capital | Article |
| 2014-04-23 | $30.0M | B | Khosla Ventures | Article |
| 2015-02-04 | $50.0M | C | Lightspeed Venture Partners | Article |
| 2016-01-08 | $100.0M | D | OrbiMed | Article |
| 2017-05-12 | $360.0M | E | SoftBank Group | Article |